Retraction.

Abstract

RetractionRetractionPublished Online:01 Nov 2016https://doi.org/10.1152/ajpendo.zh1-7671-retr.2016Retracted articleMoreSectionsPDF (31 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat Volume 299, October 2010Berglund ED, Kang L, Lee-Young RS, Hasenour CM, Lustig DG, Lynes SE, Donahue EP, Swift LL, Charron MJ, Wasserman DH. Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARα and FGF21 transcripts in vivo. Am J Physiol Endocrinol Metab 299: E607–E614, 2010. First published 28 September 2010; doi: https://doi.org/10.1152/ajpendo.00263.2010.The first author, senior author, and Vanderbilt University request retraction of this article because Figure 6 contains errors in its preparation. Specifically, several Western blots were duplicated within the figure. In addition, Western blots in Figure 6 were also published as independent experiments representing distinct experimental conditions in a 2009 Journal of Clinical Investigation article (Fig. 5, D and G; Berglund et al. J Clin Invest 119: 2412–2422, 2009) and a 2011 Diabetes article (Fig. 4K; Berglund et al. Diabetes 60: 2720–2729, 2011). The first author takes full responsibility for these errors and apologizes to the coauthors, this Journal, and its readers.This article has no references to display. Download PDF Previous Back to Top Next FiguresReferencesRelatedInformation Collections Related ArticlesGlucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARα and FGF21 transcripts in vivo 01 Oct 2010American Journal of Physiology-Endocrinology and Metabolism More from this issue > Volume 311Issue 5November 2016Pages E850-E850 Copyright & PermissionsCopyright © 2016 the American Physiological Societyhttps://doi.org/10.1152/ajpendo.zh1-7671-retr.2016PubMed27802967History Published online 1 November 2016 Published in print 1 November 2016 Metrics